United Kingdom · Question · Written question
UIN 1335
Trastuzumab Deruxtecan
Introduced
23 July 2024
Last action
19 August 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
19 August 2024
Summary
To ask the Secretary of State for Health and Social Care, whether he has had discussions with his counterparts in (a) Scotland, (b) Wales and (c) Northern Ireland on access to Enhertu for patients with HER2-low breast cancer.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
23 July 2024
Written question
To ask the Secretary of State for Health and Social Care, whether he has had discussions with his counterparts in (a) Scotland, (b) Wales and (c) Northern Ireland on access to Enhertu for patients with HER2-low breast cancer.
Source: Commons
19 August 2024
Answer
My Rt hon. Friend, the Secretary of State for Health and Social Care, spoke with his counterparts in Scotland and Wales on his first full day in office and will continue to engage with them on a regular basis. However decisions on the availability of indi...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-07-23/1335
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1722876
- uk · wq-1722876 · source updated 19 August 2024